Is ACAD up or down today?
ACAD is down 3.32% today, last at 19.64. This stock moved -3.32% versus the prior close.
ACAD · ACAD
ACAD (ACAD) is trading at 19.64, down 3.32% on the session. ACAD sits at the 10% mark of its 52-week range, carries a 14-day RSI of 36, and trades below its 50-day average. Over the past month it is down 22.79%.
Leading the coverage: “Needham Reiterates Buy on Acadia Pharmaceuticals, Maintains $35 Price Target” (Benzinga, 4d ago). ACAD is +2.69% since story.
ACAD trades on a trailing P/E of 9.1 and is running 21.87% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
ACAD is down 3.32% today, last at 19.64. This stock moved -3.32% versus the prior close.
Leading the coverage: “Needham Reiterates Buy on Acadia Pharmaceuticals, Maintains $35 Price Target” (Benzinga, 4d ago). ACAD is +2.69% since story. Dominant story: ACADIA Pharmaceuticals Inc. (ACAD) Stock forecasts - Yahoo Finance UK (1 source, neutral) RSI is 36 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Apr 2026 – Oct 2026 (126 days) · Drag or scroll left for earlier dates
Acadia Pharmaceuticals Inc. (ACAD) stock price, news, quote and history - Yahoo Finance Australia
Acadia Pharmaceuticals Inc. (ACAD) Stock Price, News, Quote & History - Yahoo! Finance Canada
ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts - Yahoo! Finance Canada
Acadia Pharmaceuticals to report Q3FY26 results on November 4 - scanx.trade
Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026